Form 4: Synaptogenix Director Acquires Stock Options

Jonathan Schechter, a director of Synaptogenix, Inc., acquired stock options exercisable for 800 shares of common stock on April 8, 2024.

Summary

• On April 8, 2024, Jonathan Schechter, a director of Synaptogenix, Inc., acquired stock options.
• The options are exercisable for 800 shares of common stock at a price of $5.39 per share.
• The options vest after one year of service from April 8, 2024, and expire on April 8, 2034.
• Following the transaction, Schechter directly owns options for 800 shares.

Sentiment

Score: 5

Explanation: Neutral sentiment. This is a routine filing indicating a director's acquisition of stock options, which doesn't inherently suggest positive or negative implications.

Positives

• A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership of securities by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.

Stakeholder Impact

• The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment, as it may signal confidence in the company's future prospects.

Key Dates

Keywords

Synaptogenix, Stock Options, Director, Beneficial Ownership, Form 4, SNPX, Jonathan Schechter